Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (351-360 of 405) with videos related to

Pageof 41
Sort By:
European Heart Journal. Acute Cardiovascular Care|January 3, 2024
Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelinesAntonio Landi, Victor Aboyans, Dominick J Angiolillo, et al.
European Heart Journal|June 17, 2015
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of CardiologyNeville Jackson, Dan Atar, Maria Borentain, et al.
Heart (British Cardiac Society)|September 21, 2016
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillationA John Camm, Gabriele Accetta, Giuseppe Ambrosio, et al.
European Heart Journal|July 1, 2011
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of CardiologyPhilippe Gabriel Steg, Kurt Huber, Felicita Andreotti, et al.
European Journal of Heart Failure|August 19, 2020
The cancer patient and cardiologyJosé Luis Zamorano, Christer Gottfridsson, Riccardo Asteggiano, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 4, 2023
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)Eliano Pio Navarese, Antonio Landi, Angelo Oliva, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 30, 2023
Antithrombotic treatment strategies in patients with established coronary atherosclerotic diseaseMarco Valgimigli, Victor Aboyans, Dominick Angiolillo, et al.
Data in Brief|August 11, 2017
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary interventionGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
International Journal of Cardiology|June 22, 2017
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trialsGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
Trials|May 25, 2020
Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trialAnna Meta Dyrvig Kristensen, Ann Bovin, Ann Dorthe Zwisler, et al.
Pageof 41

Showing results (351-360 of 405) with videos related to

Sort By:
Pageof 41
European Heart Journal. Acute Cardiovascular Care|January 3, 2024
Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelinesAntonio Landi, Victor Aboyans, Dominick J Angiolillo, et al.
European Heart Journal|June 17, 2015
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of CardiologyNeville Jackson, Dan Atar, Maria Borentain, et al.
Heart (British Cardiac Society)|September 21, 2016
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillationA John Camm, Gabriele Accetta, Giuseppe Ambrosio, et al.
European Heart Journal|July 1, 2011
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of CardiologyPhilippe Gabriel Steg, Kurt Huber, Felicita Andreotti, et al.
European Journal of Heart Failure|August 19, 2020
The cancer patient and cardiologyJosé Luis Zamorano, Christer Gottfridsson, Riccardo Asteggiano, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 4, 2023
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)Eliano Pio Navarese, Antonio Landi, Angelo Oliva, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 30, 2023
Antithrombotic treatment strategies in patients with established coronary atherosclerotic diseaseMarco Valgimigli, Victor Aboyans, Dominick Angiolillo, et al.
Data in Brief|August 11, 2017
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary interventionGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
International Journal of Cardiology|June 22, 2017
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trialsGianluca Campo, Rita Pavasini, Giampaolo Morciano, et al.
Trials|May 25, 2020
Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trialAnna Meta Dyrvig Kristensen, Ann Bovin, Ann Dorthe Zwisler, et al.
Pageof 41